Telix Completes BiPASS Enrollment and Aligns With FDA
MELBOURNE, Australia and INDIANAPOLIS, September 2, 2026 Telix Pharmaceuticals Limited has completed enrollment of 350 patients in its Phase...
MRI
Advertisement
Subtle Medical Expands AI Imaging Leadership With Tanenbaum
Menlo Park, California, August 20, 2026 Subtle Medical, a provider of AI-powered medical imaging solutions, has appointed Lawrence N....
Leads Biolabs Gains China IND for Opamtistomig in mCRC
NANJING, China, August 3, 2026 Leads Biolabs announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
Avenda Health Expands Unfold AI Across Prostate Cancer Care
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
Smith+Nephew Sets New Standard in Sports Medicine AI
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
Advertisements
SimBioSys, Ferrum Expand AI Breast Surgery Planning
CHICAGO, Ill., July 23, 2026 SimBioSys®, an AI-driven precision medicine company, has announced a strategic partnership with Ferrum Health...
CervoMed Reports Positive Clinical, Biomarker and MRI Data for Neflamapimod at AAIC 2026
BOSTON, July 14, 2026 CervoMed presented new clinical, plasma biomarker, pharmacokinetic, and imaging analyses at the Alzheimer’s Association International...
INmune Bio Reports Positive Phase 2 XPro Data
INmune Bio, BOCA RATON, Fla., July 9, 2026 INmune Bio Inc. announced positive new imaging findings from its Phase...
Viz.ai Expands AI Platform Into Neurodegenerative Disease
SAN FRANCISCO | July 9, 2026 Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, has announced...
Satellos Reports Positive Six-Month SAT-3247 Data
TORONTO, July 8, 2026 Satellos Bioscience Inc. announced encouraging six-month interim data from its ongoing Phase 2 TRAILHEAD clinical...
Advertisement
